Mrs. Sara Elizabeth George, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 45012 W Honeycutt Ave, Maricopa, AZ 85239 Phone: 520-568-5160 |
Amy Elizabeth Morrison, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 18150 N Alterra Pkwy, Maricopa, AZ 85139 Phone: 520-568-5160 |
Miss Taylor Mccarthy, MA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 19845 N Costa Del Sol, Maricopa, AZ 85138 Phone: 520-568-5170 |
Mrs. Linda Susan Shields, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 45012 W Honeycutt Ave, Maricopa, AZ 85239 Phone: 520-568-8118 |
Mrs. Lois Anne Caballero, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 45012 W Honeycutt Ave, Maricopa, AZ 85239 Phone: 520-466-5698 |
Jamie Harpster Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 18600 N Porter Rd, Maricopa, AZ 85138 Phone: 520-568-6110 |
Kennedy Bannon, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 18150 N Alterra Pkwy, Maricopa, AZ 85139 Phone: 520-568-5160 |
Mrs. Judith Daugherty Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 36851 W Mondragone Ln, Maricopa, AZ 85138 Phone: 602-341-1141 |
Melody A Traylor, MA CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 43603 W Kramer Ln, Maricopa, AZ 85238 Phone: 520-568-6701 |
Mrs. Izlia A Morales De Fitzgerald, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 45012 W Honeycutt Ave, Maricopa, AZ 85239 Phone: 520-568-8118 |
Ms. Heather Zirpel, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 40760 W Novak Ln, Maricopa, AZ 85238 Phone: 480-650-5093 |
News Archive
Strokes are a leading cause of mortality and adult disability. Those that involve intracerebral hemorrhage are especially deadly, and there are no effective treatments to control such bleeding. Moreover, diabetes and hyperglycemia are associated with increases in bleeding during hemorrhagic stroke and worse clinical outcomes.
Sanofi Pasteur, the vaccines division of Sanofi, announced today that the U.S. Food and Drug Administration (FDA) has expanded the approved age indication of Adacel® (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed; Tdap) for active booster immunization for the prevention of tetanus, diphtheria, and pertussis as a single dose in persons 10 through 64 years of age.
Techulon™ Inc., an early stage life sciences company based in the Virginia Tech Corporate Research Center, has signed an exclusive license with Virginia Tech Intellectual Properties Inc. to market a new theranostic transfection reagent. This new traceable reagent complements Techulon's currently marketed Glyocofect™ transfection platform and expands the company's offering in an $800 million market that is steadily growing at 15% annually.
Rutgers University and two collaborators have received a $3.4 million research grant to develop tools aimed at improving the identification of prostate cancer using MRI, or magnetic resonance imaging.
› Verified 6 days ago